Bioage Labs, Stock Probability of Future Stock Price Finishing Under 18.78
| BIOA Stock | 19.14 0.70 3.80% |
BioAge |
BioAge Labs, Target Price Odds to finish below 18.78
The tendency of BioAge Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to 18.78 or more in 90 days |
| 19.14 | 90 days | 18.78 | about 8.23 |
Based on a normal probability distribution, the odds of BioAge Labs, to drop to 18.78 or more in 90 days from now is about 8.23 (This BioAge Labs, probability density function shows the probability of BioAge Stock to fall within a particular range of prices over 90 days) . Probability of BioAge Labs, price to stay between 18.78 and its current price of 19.14 at the end of the 90-day period is roughly 2.86 .
Given the investment horizon of 90 days BioAge Labs, has a beta of 0.68 suggesting as returns on the market go up, BioAge Labs, average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding BioAge Labs, will be expected to be much smaller as well. Additionally BioAge Labs, has an alpha of 0.1652, implying that it can generate a 0.17 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). BioAge Labs, Price Density |
| Price |
Predictive Modules for BioAge Labs,
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as BioAge Labs,. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.BioAge Labs, Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. BioAge Labs, is not an exception. The market had few large corrections towards the BioAge Labs,'s value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold BioAge Labs,, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of BioAge Labs, within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.17 | |
β | Beta against Dow Jones | 0.68 | |
σ | Overall volatility | 2.15 | |
Ir | Information ratio | 0.02 |
BioAge Labs, Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of BioAge Labs, for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for BioAge Labs, can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| BioAge Labs, had very high historical volatility over the last 90 days | |
| BioAge Labs, has high likelihood to experience some financial distress in the next 2 years | |
| BioAge Labs, has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Net Loss for the year was (63.85 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| BioAge Labs, currently holds about 4.63 M in cash with (37.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04. | |
| Latest headline from gurufocus.com: BioAge Labs to Present at Upcoming Investor Conferences |
BioAge Labs, Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of BioAge Stock often depends not only on the future outlook of the current and potential BioAge Labs,'s investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. BioAge Labs,'s indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 33.7 M | |
| Cash And Short Term Investments | 21.6 M |
BioAge Labs, Technical Analysis
BioAge Labs,'s future price can be derived by breaking down and analyzing its technical indicators over time. BioAge Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of BioAge Labs,. In general, you should focus on analyzing BioAge Stock price patterns and their correlations with different microeconomic environments and drivers.
BioAge Labs, Predictive Forecast Models
BioAge Labs,'s time-series forecasting models is one of many BioAge Labs,'s stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary BioAge Labs,'s historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about BioAge Labs,
Checking the ongoing alerts about BioAge Labs, for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for BioAge Labs, help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| BioAge Labs, had very high historical volatility over the last 90 days | |
| BioAge Labs, has high likelihood to experience some financial distress in the next 2 years | |
| BioAge Labs, has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Net Loss for the year was (63.85 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| BioAge Labs, currently holds about 4.63 M in cash with (37.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04. | |
| Latest headline from gurufocus.com: BioAge Labs to Present at Upcoming Investor Conferences |
Check out BioAge Labs, Backtesting, BioAge Labs, Valuation, BioAge Labs, Correlation, BioAge Labs, Hype Analysis, BioAge Labs, Volatility, BioAge Labs, History as well as BioAge Labs, Performance. For information on how to trade BioAge Stock refer to our How to Trade BioAge Stock guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioAge Labs,. If investors know BioAge will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioAge Labs, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.40) |
The market value of BioAge Labs, is measured differently than its book value, which is the value of BioAge that is recorded on the company's balance sheet. Investors also form their own opinion of BioAge Labs,'s value that differs from its market value or its book value, called intrinsic value, which is BioAge Labs,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioAge Labs,'s market value can be influenced by many factors that don't directly affect BioAge Labs,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioAge Labs,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if BioAge Labs, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioAge Labs,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.